5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole Yoshihiko MaeharaYoshihisa SakaguchiKeizo Sugimachi Original Articles Pages: 257 - 260
Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4′-amino-3′-hydroxy-doxorubicin Romano DanesiNunzia BernardiniMario Del Tacca Original Articles Pages: 261 - 265
Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a and its mechanism of action Shiro AkinagaTadashi AshizawaMasami Okabe Original Articles Pages: 266 - 272
In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line Mika KurokiShuji NakanoYoshiyuki Niho Original Articles Pages: 273 - 276
O 6-Methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents Roberta BianchiLorenzo CittiMaria Cristina Fioretti Original Articles Pages: 277 - 282
Expression of the mdr1 gene in human colorectal carcinomas: relationship with multidrug resistance inferred from analysis of human colorectal carcinoma cell lines Giuseppe ToffoliAlessandra VielMauro Boiocchi Original Articles Pages: 283 - 289
In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines Alem GhiorghisAbdolhossen TalebianRobert Clarke Original Articles Pages: 290 - 296
Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro Eugen MuschMouhamad MalekEberhard Riedel Original Articles Pages: 297 - 304
Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer Elizabeth RosyoldRussell SchilderPeter J. O'Dwyer Original Articles Pages: 305 - 308
Long-term studies of cisplatin-induced reductions in porcine renal functional reserve Mike E. C. RobbinsTony BywatersElizabeth Whitehouse Original Articles Pages: 309 - 315
Pharmacokinetics of high-dose etoposide after short-term infusion P. KöhlH. KöpplerH. Jungclas Original Articles Pages: 316 - 320
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus Andreas HarstrickCarsten BokemeyerHansjochen Wilke Original Articles Pages: 321 - 322
Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation Raymond LiangT. K. ChanDavid Todd Short Communication Pages: 323 - 325
Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study C. J. A. PuntP. H. M. de MulderD. J. Th. Wagener Short Communication Pages: 326 - 328
Interferon-related cortical blindness Ofer MerimskyPuiu NisipeanuSamario Chaitchik Short Communication Pages: 329 - 330
The distribution ofo,p′-DDD (Mitotane) among serum lipoproteins in normo- and hypertriglyceridemia D. O. E. GebhardtA. J. MoolenaarJ. A. Gevers Leuven Short Communication Pages: 331 - 334
Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic data Ate van der GaastPieter SonneveldTed A. W. Splinter Short Communication Pages: 335 - 337